Editas Medicine announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and Strategy Officer. Ms. Deardorf will build and lead Editas Medicine’s commercial organization, strategy, and execution to support all launch, commercialization, and lifecycle management activities of the Company’s current and future pipeline of products. Most recently, Ms. Deardorf served as the Chief Commercial Officer of Magenta Therapeutics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EDIT:
- Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer
- Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
- Editas Medicine Announces Upcoming Investor Events
- Medicenna Therapeutics appoints Jeff Caravella as CFO
- Biotech Alert: Searches spiking for these stocks today